ID   P493-6
AC   CVCL_6783
SY   P-493-6; p493-6
DR   BTO; BTO:0003291
DR   DSMZ; ACC-915
DR   DSMZCellDive; ACC-915
DR   Millipore; SCC279
DR   PRIDE; PXD000589
DR   Wikidata; Q54937296
RX   PubMed=10956386;
RX   PubMed=25894527;
CC   Characteristics: The expression of the MYC gene is under the control of a tetracycline regulated promoter.
CC   Doubling time: ~36 hours (DSMZ=ACC-915).
CC   Transfected with: HGNC; 7553; MYC.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Cell surface proteome.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-915; Millipore=SCC279
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 13
ST   D19S433: 13,14
ST   D21S11: 28,32.2
ST   D2S1338: 17,21
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 9,13
ST   FGA: 22
ST   Penta D: 11,13
ST   Penta E: 12,14
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W845 ! EREB2-5
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
RX   PubMed=10956386; DOI=10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6;
RA   Pajic A., Spitkovsky D., Christoph B., Kempkes B., Schuhmacher M.,
RA   Staege M.S., Brielmeier M., Ellwart J.W., Kohlhuber F., Bornkamm G.-W.,
RA   Polack A., Eick D.;
RT   "Cell cycle activation by c-myc in a Burkitt lymphoma model cell
RT   line.";
RL   Int. J. Cancer 87:787-793(2000).
//
RX   PubMed=25894527; DOI=10.1371/journal.pone.0121314;
RA   Bausch-Fluck D., Hofmann A., Bock T., Frei A.P., Cerciello F.,
RA   Jacobs A., Moest H., Omasits U., Gundry R.L., Yoon C., Schiess R.,
RA   Schmidt A., Mirkowska P., Hartlova A.S., Van Eyk J.E., Bourquin J.-P.,
RA   Aebersold R., Boheler K.R., Zandstra P.W., Wollscheid B.;
RT   "A mass spectrometric-derived cell surface protein atlas.";
RL   PLoS ONE 10:E0121314-E0121314(2015).
//